[LY188011 phase I study. Research Group of Gemcitabine (LY188011)].
Taguchi T, Furuse K, Fukuoka M, Shimoyama T, Morimoto K, Nakamura T, Furue H, Majima H, Niitani H, Ohta K, Wakui A, Nakao I, Tsukagoshi S.
Taguchi T, et al.
Gan To Kagaku Ryoho. 1996 Jul;23(8):1011-8.
Gan To Kagaku Ryoho. 1996.
PMID: 8687215
Clinical Trial.
Japanese.